Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Free Realtime Quote INR

Vista Pharmaceuticals Limited (VISTAPH.BO)

Compare
11.40
-0.40
(-3.23%)
As of 12:25:01 PM GMT+5:30. Market Open.
Loading Chart for VISTAPH.BO
  • Previous Close 11.80
  • Open 11.35
  • Bid 11.39 x --
  • Ask 11.40 x --
  • Day's Range 11.35 - 12.38
  • 52 Week Range 9.10 - 13.09
  • Volume 4,636
  • Avg. Volume 12,476
  • Market Cap (intraday) 701.692M
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) --
  • EPS (TTM) -0.51
  • Earnings Date May 26, 2025 - May 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.

www.vistapharmaceuticals.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: VISTAPH.BO

View More

Performance Overview: VISTAPH.BO

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

VISTAPH.BO
3.23%
S&P BSE SENSEX (^BSESN)
1.69%

1-Year Return

VISTAPH.BO
3.39%
S&P BSE SENSEX (^BSESN)
4.65%

3-Year Return

VISTAPH.BO
3.39%
S&P BSE SENSEX (^BSESN)
31.67%

5-Year Return

VISTAPH.BO
3.39%
S&P BSE SENSEX (^BSESN)
152.85%

Compare To: VISTAPH.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VISTAPH.BO

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    726.31M

  • Enterprise Value

    768.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.49

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    7.70

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.69%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    99.77M

  • Net Income Avi to Common (ttm)

    -30.62M

  • Diluted EPS (ttm)

    -0.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.38M

  • Total Debt/Equity (mrq)

    14.20%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VISTAPH.BO

View More

Company Insights: VISTAPH.BO

Research Reports: VISTAPH.BO

View More

People Also Watch